<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Reliable mite-specific IgE testing in nasal secretions by means of allergen microarray</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
				<date type="published" when="2017-01-10">January 10, 2017.</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<title level="a" type="main">Reliable mite-specific IgE testing in nasal secretions by means of allergen microarray</title>
					</analytic>
					<monogr>
						<imprint>
							<date type="published" when="2017-01-10">January 10, 2017.</date>
						</imprint>
					</monogr>
					<idno type="MD5">49C6B5F5669F242DC58A406C5AF6AC34</idno>
					<idno type="DOI">10.1016/j.jaci.2016.11.033</idno>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2-SNAPSHOT" ident="GROBID" when="2022-05-18T11:36+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<abstract/>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>To the Editor:</head><p><s>Because there is evidence for local production of IgE in the nasal mucosa, <ref type="bibr" target="#b0">[1]</ref><ref type="bibr" target="#b1">[2]</ref><ref type="bibr" target="#b2">[3]</ref> methods to measure allergen-specific IgE (sIgE) at nasal level in patients with allergic rhinitis (AR) are of great interest.</s><s>]<ref type="bibr" target="#b6">[7]</ref> Nevertheless, IgE ''classic'' assays, based on immunoenzymatic methods and allergen extracts, require large volumes and are inefficient in detecting the low amounts of IgE in NasSec.</s><s>Microarray biochips allow simultaneous measurement of IgE against several allergen molecules with excellent sensitivity and specificity. <ref type="bibr" target="#b7">8,</ref><ref type="bibr" target="#b8">9</ref></s><s>To our knowledge, this technology has never been tested in NasSec of patients with AR.</s><s>To fill this gap, we tested the performance of a customized microarray containing 15 house dust mite (HDM) allergen molecules based on the Immunoassay capture test (ImmunoCAP) ImmunoCAP solid-phase allergen chip technology (Thermo Fisher Scientific, Uppsala, Sweden) for sIgE detection in NasSec of 30 adult patients with HDM-AR and 29 nonallergic controls (see Table <ref type="table" target="#tab_3">E1</ref> in this article's Online Repository at www.jacionline.org).</s><s>All subjects were recruited via the Department of Otorhinolaryngology in Ghent University Hospital (Belgium).</s><s>HDM-AR was defined by a consistent history and a positive skin prick test (SPT) result to Dermatophagoides pteronyssinus and/or Dermatophagoides farinae (ALK Abell o, The Netherlands).</s><s>Controls were volunteers without history of any allergy, and negative SPT results.</s><s>Eligible subjects underwent collection of serum and NasSec.</s><s>After collection with filter disks (FDs) and sinus packs (SPs) (Fig <ref type="figure" target="#fig_0">1,</ref> A and B), NasSec were processed and diluted with saline (''fixed dilution processing,'' ie, FD, 1:20; SP, 1:10).</s></p><p><s>Thirteen patients with AR underwent additional collections of serum and NasSec on a following visit.</s><s>In this second test, NasSec were collected with 3 different absorbent devices: FDs, ear packs (EPs), and SPs.</s><s>This time, NasSec were diluted with a fixed volume of saline (''fixed volume processing,'' ie, FD, 1 mL; SP, 2 mL; EP, 3 mL).</s><s>Further details are provided in this article's Online Repository at www.jacionline.org.</s></p><p><s>Total IgE and sIgE to HDM extract were measured in sera and NasSec with ImmunoCAP-fluorescent enzyme immunoassay (TFS, Uppsala, Sweden).</s><s>HDM sIgE were detected in serum of all 30 patients with AR, but only in 21 FD and 22 SP samples (see  <ref type="table" target="#tab_5">E3</ref> in this article's Online Repository at www.jacionline.org).</s></p><p><s>Among the patients with AR, the prevalence of sIgE to 13 of the 15 examined HDM molecules was similar in serum and NasSec: 83% to 97% for group 2 molecules (rDer p 2, rDer f 2); 70% to 87% for rDer p 23; 20% to 33% for rDer p 5 and rDer p 7; and 0% to 23% for all others.</s><s>In contrast, sIgE to group 1 molecules (nDer p 1, nDer f 1) was detected frequently in serum (80% to 83%), but less so in NasSec (37% to 60%).</s><s>In both serum and NasSec of the 29 controls, sIgE was undetectable, except for IgE to rDer p 5 detected in 4 SP samples (see Table <ref type="table" target="#tab_6">E4</ref> in this article's Online Repository at www.jacionline.org).</s></p><p><s>Detection of IgE to at least 1 of the major allergen molecules (nDer p 1, nDer f 1, rDer p 2, rDer f 2, rDer p23) in NasSec predicted with high sensitivity and excellent specificity the allergic status of the patient and the outcome in serum (specificity 100% for both FDs and SPs; sensitivity 90% for FDs and 87% for SPs; Table <ref type="table" target="#tab_2">I</ref>).</s><s>With the FD method, the sensitivity of the microarray to identify patients with AR was significantly higher than that of the ImmunoCAP (27 of 30, 90% vs 21 of 30, 70%; P 5 .05).</s></p><p><s>Levels of IgE to the HDM molecules in NasSec collected with FDs and SPs were highly related to one another (r s , 0.78; P &lt;.001) and to the levels in serum (FDs, r s , 0.43, P &lt; .001;</s><s>SP, r s , 0.45, P &lt; .001;</s><s>Fig <ref type="figure" target="#fig_0">1, C</ref>).</s></p><p><s>The results of the first test were generally reproduced in the second test.</s><s>Moreover, this time, the prevalence of sIgE to group 1 molecules in serum and NasSec was more similar (serum, 77%; NasSec, 62%-77%; see Tables <ref type="table" target="#tab_8">E5 and E6</ref>  We pioneered the use of an allergen microarray chip for sIgE detection in NasSec of patients with AR.</s><s>Our customized microarray detected sIgE to HDM molecules in NasSec with a good sensitivity, superior to ImmunoCAP-fluorescent enzyme immunoassay in detecting IgE to HDM extracts in the same samples.</s><s>Moreover, the microarray results in NasSec were very predictive for the serum results.</s><s>Hence, testing nasal IgE to allergen molecules by a microarray approach may soon become a noninvasive alternative in the diagnostic workup of AR.</s><s>In addition, our findings may offer new perspectives for research on ''Local Allergic Rhinitis,'' a subset of rhinitis characterized by sIgE at the nasal level without systemic allergy. <ref type="bibr" target="#b4">5</ref></s><s>he high accuracy of the microarray approach was very robust with all the methods used for NasSec collection (FDs, EPs, SPs) and processing (''fixed volume'' and ''fixed dilution'').</s><s>The best performance was obtained with FDs, which are smaller in size and more acceptable for the patient.</s><s>NasSec were quite highly diluted during processing, but high diagnostic accuracy was also obtained  in some less diluted samples of the second test, raising the question whether a lower dilution (eg, 1:4) might be used to further improve the test sensitivity.</s></p><p><s>A limitation of our study is the possibility that IgG 4 antibodiesnot measured in our samples-may have exerted competitive effects to IgE binding in our microarray.</s><s>Also, the selected cutoff (ie, 0.03 ISU for diluted NasSec) cannot be automatically applied in other settings or to other microarrays.</s><s>Large-scale studies are needed to confirm our promising findings.</s><s>The technique should be investigated in more heterogeneous patient populations and with other airborne allergens.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>IgG trough levels and progression of pulmonary disease in pediatric and adult common variable immunodeficiency disorder patients</head><p><s>To the Editor:</s></p><p><s>Common variable immunodeficiency disorder (CVID) is the most prevalent symptomatic primary immunodeficiency in adults and children.</s><s>Patients encounter recurrent bacterial and viral infections of the respiratory tract, with delayed pathogen clearance due to diminished immunoglobulin levels and insufficient specific antibody responses to encapsulated bacteria.</s><s>As a result, the most prevalent comorbidities in adult CVID are recurrent pneumonia (32%) and chronic lung disease (28%), with lung failure being the most prevalent cause of death. <ref type="bibr" target="#b0">1</ref> Pulmonary comorbidities include structural airway disease (AD) due to recurrent pulmonary infections and interstitial lung disease (ILD), in particular in patients with autoimmune phenomena. <ref type="bibr" target="#b1">2</ref></s><s>oth disease entities are well detected by high-resolution computed tomography (CT). <ref type="bibr" target="#b1">2,</ref><ref type="bibr" target="#b2">3</ref></s><s>In this study, we investigated progression of pulmonary disease in pediatric and in adult CVID patients in a 3-to 5-year follow-up period using a uniform CT scanning and scoring protocol. <ref type="bibr" target="#b3">4,</ref><ref type="bibr" target="#b4">5</ref></s><s>ediatric and adult CVID patients were allocated to low-or high-risk profiles for AD and/or ILD disease progression.</s><s>This was based on baseline AD and ILD scores, defined comorbidities, and/or immunological parameters (Table <ref type="table" target="#tab_2">I</ref> and see this article's Methods section in the Online Repository at www.jacionline.</s><s>org).</s><s>4]<ref type="bibr" target="#b4">[5]</ref> Patients underwent follow-up scanning after 2 to 3 years (adult and pediatric high-risk patients) or 5 years (low-risk patients).</s><s>Pulmonary function tests (PFTs) were performed at baseline for all patients and at follow-up when clinically necessary (24 of 55; 43% of cases) as determined in our institutional protocol for follow-up of CVID patients.</s><s>PFT test results were mostly within normal ranges at baseline and at follow-up (see Table <ref type="table" target="#tab_3">E1</ref> in this article's Online Repository at www.jacionline.org).</s><s>All patients were treated with immunoglobulin replacement therapy.</s><s>Antibiotic prophylaxis was prescribed in patients with a history of recurrent pulmonary infections despite immunoglobulin therapy</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>METHODS Subjects</head><p><s>The local ethical committee of Ghent University Hospital approved the study.</s><s>All subjects gave written informed consent before inclusion.</s></p><p><s>All subjects underwent an SPT to 8 locally relevant airborne allergen extracts (grass mix, tree mix, Artemisia vulgaris, Dermatophagoides pteronyssinus, Dermatophagoides farinae, cat, dog, and Alternaria; ALK Abell o).</s><s>Subjects with acute bacterial/viral rhinosinusitis at the moment of testing were excluded from the study.</s><s>Intake of oral antihistamines, nasal decongestants, and nasal or systemic corticosteroids was discontinued in the week before the study visits.</s><s>None of the subjects had ever been treated with allergen-specific immunotherapy or anti-IgE antibodies (omalizumab).</s><s>All subjects completed questionnaires on general health and allergy.</s></p><p><s>Sample collection for the first test was performed in 30 patients with AR and 29 nonallergic controls between November 2013 and August 2016.</s><s>Sample collection for the second test was performed in 13 patients with AR between January and March 2015, in the 15 patients whose first sample had been taken between November 2013 and March 2014.</s><s>Patients with AR and control subjects were comparable in terms of age and sex (clinical characteristics are presented in Table <ref type="table" target="#tab_3">E1</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Statistics</head><p><s>Sensitivity and specificity, positive and negative predictive values, accuracy, and positive and negative likelihood ratios of IgE tests in NasSec were calculated with 2-by-2 tables, using the results of IgE tests in serum as a reference.</s><s>Intrapatient comparisons of IgE levels were performed with Spearman rank correlation and a P value of less than .05</s><s>was considered statistically significant.</s><s>Statistical analyses were performed with R Core Team (2014), version 3.2.3.</s><s>Graphs were created with Graphpad Prism version 6.00 (La Jolla, Calif).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Collection and processing of NasSec</head><p><s>Three different absorptive devices were used in this study for collection of NasSec: FDs, EPs, and SPs.</s><s>FDs are punched out of Shandon filter paper cards (No. 190005; Shandon, Pittsburgh, Pa) using a 10-mm punch.</s><s>SPs and EPs are commercially available sponges, for this study provided by Fabco (Ivalon; New London, Conn): ''Post-Op Sinus Packing'' (K9, 4000plus, 3.5 cm long 3 0.9 cm wide 3 1.2 cm high) and ''Small Post-Op Ear Packing'' (2.4 cm long 3 1.2 cm diameter).</s><s>The FDs, SPs, and EPs are sealed in pairs in 15-mL tubes (Falcon, Becton-Dickinson Labware, Lincoln Park, NJ) and are preweighed.</s><s>Under direct visualization, using a surgical headlight, a speculum, and bayonet forceps, the FDs, SPs, or EPs are placed in the nasal cavity (1 per nostril).</s><s>FDs are placed on the anterior third of the nasal septum, E1 whereas SPs and EPs are inserted on the floor of the cavity between the septum and inferior turbinate.</s><s><ref type="bibr">E2</ref> The devices are left in the nose for 5 minutes, are than removed, placed back in their respective 15-mL tube, and weighed again.</s><s>The weight of collected Nas-Sec (WNS) is determined by comparing the weights of the devices in their respective Falcon tubes before and after collection, using the same balance.</s><s><ref type="bibr">E2</ref> After collection, an amount of physiologic saline (0.9% NaCl) is added to mobilize the NasSec from the device, resulting in diluted samples.</s><s>For the first test, NasSec were processed with a fixed dilution: FD samples were diluted 1:20, SP samples 1:10.</s><s>To obtain this fixed dilution, the amount of saline to be added, needs to be calculated for each sample: X (mL) 5 WNS 3 (DF -1) (DF, dilution factor; WNS, weight of collected NS; X, volume of saline to be added).</s></p><p><s>For the second test, NasSec were processed with a fixed volume: 1 mL was added to FD samples, 2 mL to EP samples, and 3 mL to SP samples.</s><s>Hence, the dilution differs for each sample and needs to be calculated for each sample: DF5WNS1XðmLÞ=WNS.</s><s>After addition of saline, samples are stored at 48C for 2 hours.</s><s>Subsequently, the devices are placed in the shaft of a 5-mL syringe (Becton-Dickinson S.A.), placed back in their respective tube, and squeezed out with the piston of the syringe.</s><s>The samples are then centrifuged (1500g, 15 minutes, 48C) to extract all fluid.</s><s>Finally, the supernatants are aliquoted and stored at 2208C until analysis.</s></p><p><s>Because the NasSec samples were diluted during processing, measured levels of total IgE and sIgE needed to be corrected afterward: levels were multiplied with the corresponding dilution factor to estimate the levels in NasSec samples before they were diluted.</s></p><p><s>For fixed dilution processing, the cutoff of 0.2 kU/L (ImmunoCAP) in the diluted samples reflects a cutoff of 4.0 kU/L for FDs and 2.0 kU/L for SPs in the undiluted samples; the cutoff of 0.03 ISU (allergen microarray) in the diluted samples reflects a cutoff of 0.6 ISU for FDs and 0.3 ISU for SPs in the undiluted samples.</s><s>Because fixed volume processing results in a different dilution for each sample, the cutoff points of 0.2 kU/L and 0.03 ISU in the diluted samples correspond to different cutoff points in the undiluted samples.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Selecting the cutoff in NasSec</head><p><s>Sensitivity and specificity of IgE tests in NasSec were calculated for different cutoffs, with IgE tests in serum as reference.</s><s>The best balance of sensitivity and specificity was achieved with a cutoff of 0.03 ISU or more in diluted NasSec for all the 15 molecules and for at least 1 of the major allergen molecules of groups 1 (nDer p 1, nDer f 1), 2 (rDer p 2, rDer f 2), and 23 (rDer p 23) (Table <ref type="table" target="#tab_5">E3</ref>).</s><s>Therefore, this cutoff was selected for further analyses.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Prevalence of sIgE to group 1 molecules: Difference between first test and second test</head><p><s>In the first test, sIgE to group 1 molecules (nDer p 1, nDer f 1) was detected frequently in serum, but less so in NasSec.</s><s>In the second test, the prevalence of sIgE to group 1 molecules in serum and NasSec was more similar.</s><s>The second sample was collected 1 year after the first one, and we did not measure exposure to Der p 1 in the home environment of our patients.</s><s>Therefore, we cannot ascertain whether this variation is due to (1) differences in allergen exposure;</s></p><p><s>(2) an increased local (nasal) production of IgE against group 1 molecules; or (3) a very specific, although unknown, methodological issue in the first determination.</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>FIG 1 .</head><label>1</label><figDesc><div><p><s>FIG 1. Methodology and results of IgE determination in NasSec.</s><s>A, The 3 devices used to collect NasSec.</s><s>B, Positioning sinus pack in the nostril.</s><s>C, Relationship between levels (ISU) of detectable IgE to the 15 HDM molecules detected in NasSec (y-axis), collected with FDs and SPs, and serum (x-axis) in 30 patients with AR (first test).</s><s>The Spearman rank correlation coefficients (r s ) and the respective P values are shown.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head></head><label></label><figDesc><div><p><s>FIG E1.</s><s>IgE levels (ISU) to all 15 HDM allergen molecules detected in each patient with AR (n 5 13) at 2 different time points (test 1 and test 2) in the 3 samples, respectively: serum (A), FDs (B), and SPs (C).</s><s>The Spearman rank correlation coefficients (r s ) and the respective P values are shown.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head>Table E2</head><label>E2</label><figDesc><div><p><s>p 23, clone 16, and nDer f 1 and rDer f 2 were measured with the microarray in serum (cutoff &gt; _0.10 ImmunoCAP solid-phase allergen chip Standardized Units [ISU]) and NasSec (cutoff &gt; _0.03 ISU in diluted NasSec).</s><s>The cutoff in NasSec was selected on the basis of sensitivity and specificity analyses of sIgE tests in NasSec for different cutoffs (see details in Table</s></p></div></figDesc><table /><note><p><s>in this article's Online Repository at www.jacionline.org).</s><s>All controls had undetectable HDM sIgE in both serum and NasSec.</s><s>Hence, HDM sIgE in NasSec predicted with 100% specificity, but poor sensitivity (FDs, 70%; SPs, 73%) the results in serum.</s><s>Specific IgE to nDer p 1, rDer p 2, rDer p 4, rDer p 5, rDer p 7, rDer p 10, rDer p 11, rDer p 14, rDer p 15, rDer p 18, rDer p 21, rDer</s></p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_2"><head>TABLE I .</head><label>I</label><figDesc><div><p><s>Prediction of HDM allergy and serum IgE responses by testing IgE in NasSec in 30 HDM-allergic patients and 29 healthy controls</s></p></div></figDesc><table><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>FD</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell></cell><cell>Sensitivity</cell><cell cols="2">Specificity</cell><cell></cell><cell>PPV</cell><cell></cell><cell>NPV</cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell>%</cell><cell>95% CI*</cell><cell>%</cell><cell>95% CI*</cell><cell>%</cell><cell>95% CI*</cell><cell>%</cell><cell>95% CI*</cell><cell>Accuracy, %</cell><cell>LR1</cell><cell>LR2</cell></row><row><cell>Any major molecules</cell><cell>90</cell><cell>73-98</cell><cell>100</cell><cell>83-100</cell><cell>100</cell><cell>82-100</cell><cell>91</cell><cell>75-98</cell><cell>95</cell><cell>N</cell><cell>0.1</cell></row><row><cell>nDer p 1</cell><cell>46</cell><cell>26-66</cell><cell>100</cell><cell>85-100</cell><cell>100</cell><cell>62-100</cell><cell>73</cell><cell>58-85</cell><cell>78</cell><cell>N</cell><cell>0.5</cell></row><row><cell>nDer f</cell><cell>68</cell><cell>46-85</cell><cell>100</cell><cell>85-100</cell><cell>100</cell><cell>73-100</cell><cell>81</cell><cell>66-91</cell><cell>86</cell><cell>N</cell><cell>0.3</cell></row><row><cell>rDer p</cell><cell>90</cell><cell>73-98</cell><cell>100</cell><cell>83-100</cell><cell>100</cell><cell>81-100</cell><cell>91</cell><cell>76-98</cell><cell>95</cell><cell>N</cell><cell>0.1</cell></row><row><cell>rDer f 2</cell><cell>90</cell><cell>73-98</cell><cell>100</cell><cell>83-100</cell><cell>100</cell><cell>81-100</cell><cell>91</cell><cell>76-98</cell><cell>95</cell><cell>N</cell><cell>0.1</cell></row><row><cell>rDer p</cell><cell>81</cell><cell>61-93</cell><cell>100</cell><cell>85-100</cell><cell>100</cell><cell>77-100</cell><cell>87</cell><cell>72-96</cell><cell>92</cell><cell>N</cell><cell>0.2</cell></row><row><cell>Other molecules</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>rDer p</cell><cell>0</cell><cell>0-53</cell><cell>98</cell><cell>90-100</cell><cell>0</cell><cell>0-99</cell><cell>88</cell><cell>77-95</cell><cell>86</cell><cell>0.0</cell><cell>1.0</cell></row><row><cell>rDer p</cell><cell>80</cell><cell>44-97</cell><cell>100</cell><cell>89-100</cell><cell>100</cell><cell>52-100</cell><cell>96</cell><cell>87-100</cell><cell>97</cell><cell>N</cell><cell>0.2</cell></row><row><cell>rDer p</cell><cell>78</cell><cell>40-97</cell><cell>100</cell><cell>90-100</cell><cell>100</cell><cell>47-100</cell><cell>96</cell><cell>87-100</cell><cell>97</cell><cell>N</cell><cell>0.2</cell></row><row><cell>rDer p</cell><cell>57</cell><cell>18-90</cell><cell>100</cell><cell>90-100</cell><cell>100</cell><cell>28-100</cell><cell>95</cell><cell>85-99</cell><cell>95</cell><cell>N</cell><cell>0.4</cell></row><row><cell>All moleculesà</cell><cell>71</cell><cell>63-77</cell><cell>100</cell><cell>99-100</cell><cell>98</cell><cell>93-100</cell><cell>93</cell><cell>91-95</cell><cell>94</cell><cell>167.4</cell><cell>0.3</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>SP</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell></cell><cell>Sensitivity</cell><cell cols="2">Specificity</cell><cell></cell><cell>PPV</cell><cell></cell><cell>NPV</cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell>%</cell><cell>95% CI*</cell><cell>%</cell><cell>95% CI*</cell><cell>%</cell><cell>95% CI*</cell><cell>%</cell><cell>95% CI*</cell><cell>Accuracy, %</cell><cell>LR1</cell><cell>LR2</cell></row><row><cell>Any major molecules</cell><cell>87</cell><cell>69-96</cell><cell>100</cell><cell>83-100</cell><cell>100</cell><cell>81-100</cell><cell>88</cell><cell>72-97</cell><cell>93</cell><cell>N</cell><cell>0.1</cell></row><row><cell>nDer p 1</cell><cell>58</cell><cell>37-78</cell><cell>100</cell><cell>85-100</cell><cell>100</cell><cell>68-100</cell><cell>78</cell><cell>63-89</cell><cell>83</cell><cell>N</cell><cell>0.4</cell></row><row><cell>nDer f</cell><cell>48</cell><cell>28-69</cell><cell>100</cell><cell>85-100</cell><cell>100</cell><cell>64-100</cell><cell>72</cell><cell>57-84</cell><cell>78</cell><cell>N</cell><cell>0.5</cell></row><row><cell>rDer p</cell><cell>86</cell><cell>68-96</cell><cell>100</cell><cell>83-100</cell><cell>100</cell><cell>80-100</cell><cell>88</cell><cell>73-97</cell><cell>93</cell><cell>N</cell><cell>0.1</cell></row><row><cell>rDer f 2</cell><cell>86</cell><cell>68-96</cell><cell>100</cell><cell>83-100</cell><cell>100</cell><cell>80-100</cell><cell>88</cell><cell>73-97</cell><cell>93</cell><cell>N</cell><cell>0.1</cell></row><row><cell>rDer p</cell><cell>81</cell><cell>61-93</cell><cell>100</cell><cell>85-100</cell><cell>100</cell><cell>77-100</cell><cell>87</cell><cell>72-96</cell><cell>92</cell><cell>N</cell><cell>0.2</cell></row><row><cell>Other molecules</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>rDer p</cell><cell>14</cell><cell>0-58</cell><cell>98</cell><cell>90-100</cell><cell>50</cell><cell>1-99</cell><cell>89</cell><cell>78-96</cell><cell>88</cell><cell>7.4</cell><cell>0.9</cell></row><row><cell>rDer p</cell><cell>70</cell><cell>35-93</cell><cell>90</cell><cell>78-97</cell><cell>58</cell><cell>28-85</cell><cell>94</cell><cell>82-99</cell><cell>86</cell><cell>6.9</cell><cell>0.3</cell></row><row><cell>rDer p</cell><cell>67</cell><cell>30-93</cell><cell>100</cell><cell>90-100</cell><cell>100</cell><cell>42-100</cell><cell>94</cell><cell>84-99</cell><cell>95</cell><cell>N</cell><cell>0.3</cell></row><row><cell>rDer p</cell><cell>57</cell><cell>18-90</cell><cell>100</cell><cell>90-100</cell><cell>100</cell><cell>28-100</cell><cell>95</cell><cell>85-99</cell><cell>95</cell><cell>N</cell><cell>0.4</cell></row><row><cell>All moleculesà</cell><cell>68</cell><cell>60-75</cell><cell>99</cell><cell>98-100</cell><cell>95</cell><cell>90-98</cell><cell>93</cell><cell>91-94</cell><cell>94</cell><cell>80.3</cell><cell>0.3</cell></row></table><note><p><s>Values in boldface are the outcomes referred to at least 1 of the major allergen molecules (nDer p 1, Der f 1, nDer p 2, rDer f 2, rDer p 23). LR1, Positive likelihood ratio; LR2, negative likelihood ratio; NPV, negative predictive value; PPV, positive predictive value.</s><s>*Exact binomial confidence limits (95% CI) for test sensitivity, specificity, PPV and NPV.</s><s>Outcomes referred to at least 1 of the major allergen molecules (nDer p 1, nDer f 1, rDer p 2, rDer f 2, rDer p 23). àIncluding outcomes of rDer p 10, rDer p 11, rDer p 14, rDer p 15, Clone 16, and rDer p 18, all characterized by a low positive sample size (n &lt; 5).</s></p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_3"><head>TABLE E1 .</head><label>E1</label><figDesc><div><p><s>Characteristics of study population</s></p></div></figDesc><table><row><cell></cell><cell cols="2">Nonallergic</cell><cell cols="2">HDM-allergic</cell><cell></cell></row><row><cell></cell><cell cols="2">subjects</cell><cell cols="2">patients</cell><cell></cell></row><row><cell></cell><cell cols="2">(n 5 29)</cell><cell cols="2">(n 5 30)</cell><cell>P</cell></row><row><cell>Characteristic</cell><cell>Median/n</cell><cell>IQR/%</cell><cell>Median/n</cell><cell>IQR/%</cell><cell>value*</cell></row><row><cell>Age (y)</cell><cell>26</cell><cell>(24.2-29.8)</cell><cell>26</cell><cell cols="2">(23.7-31.0) .458</cell></row><row><cell>Sex: female</cell><cell>22</cell><cell>75.9%</cell><cell>18</cell><cell>60.0%</cell><cell>.267</cell></row><row><cell>BMI (kg/m 2 )</cell><cell>22</cell><cell>(19.8-24.3)</cell><cell>23</cell><cell cols="2">(21.2-24.3) .110</cell></row><row><cell>Nicotin</cell><cell>1</cell><cell>3.4%</cell><cell>3</cell><cell>10.0%</cell><cell>.612</cell></row><row><cell>VAS control</cell><cell>0</cell><cell>(0-1.5)</cell><cell>34</cell><cell cols="2">(14.0-50.3) &lt;.001</cell></row><row><cell>AR (mm)</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>VAS nasal</cell><cell>2</cell><cell>(0-7)</cell><cell>25</cell><cell cols="2">(11.8-51.3) &lt;.001</cell></row><row><cell>symptoms (mm)</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>ARIA, persistent</cell><cell>NA</cell><cell>NA</cell><cell>20</cell><cell>66.7%</cell><cell>NA</cell></row><row><cell>ARIA, moderate/</cell><cell>NA</cell><cell>NA</cell><cell>15</cell><cell>50.0%</cell><cell>NA</cell></row><row><cell>severe</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>SS Nose (0-3)</cell><cell>0</cell><cell>(0-0.5)</cell><cell>1</cell><cell>(0.8-1.6)</cell><cell>&lt;.001</cell></row><row><cell>SS Nose&amp;Eye (0-3)</cell><cell>0</cell><cell>(0-0.3)</cell><cell>0.8</cell><cell>(0.7-1.5)</cell><cell>&lt;.001</cell></row><row><cell>Asthma</cell><cell>0</cell><cell>0.0%</cell><cell>9</cell><cell>30.0%</cell><cell>.002</cell></row><row><cell>ACT score (0-25)</cell><cell>25</cell><cell>(25-25)</cell><cell>25</cell><cell>(24.3-25)</cell><cell>.022</cell></row><row><cell>Monosensitized</cell><cell>NA</cell><cell>NA</cell><cell>5</cell><cell>16.7%</cell><cell>NA</cell></row><row><cell>to HDM</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row></table><note><p><s>ACT, Asthma Control Test; ARIA, Allergic Rhinitis and its Impact on Asthma; BMI, body mass index; IQR, interquartile range; NA, not applicable/available; SS, symptom score; VAS, Visual Analog Scale.</s><s>*P value for difference between nonallergic subjects and HDM-allergic patients (Mann-Whitney U test or Fisher exact test).</s></p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_4"><head>TABLE E2 .</head><label>E2</label><figDesc><div><p><s>IgE responses detected with ImmunoCAP in 30 patients with AR at the first test</s></p></div></figDesc><table><row><cell></cell><cell cols="2">Serum (IgE &gt; _ 0.1 kU/L)</cell><cell cols="2">FD (IgE &gt; _ 4 kU/L)</cell><cell cols="2">SP (IgE &gt; _ 2 kU/L)</cell></row><row><cell>Patient ID</cell><cell>Total IgE (kU/L)</cell><cell>HDM sIgE (kU/L)</cell><cell>Total IgE (kU/L)</cell><cell>HDM sIgE (kU/L)</cell><cell>Total IgE (kU/L)</cell><cell>HDM sIgE (kU/L)</cell></row><row><cell>1</cell><cell>472</cell><cell>46</cell><cell>91</cell><cell>16</cell><cell>65</cell><cell>13</cell></row><row><cell>2</cell><cell>595</cell><cell>83</cell><cell>29</cell><cell>10</cell><cell>22</cell><cell>6</cell></row><row><cell>3</cell><cell>66</cell><cell>8</cell><cell>4</cell><cell>BDL</cell><cell>BDL</cell><cell>BDL</cell></row><row><cell>4</cell><cell>307</cell><cell>34</cell><cell>105</cell><cell>25</cell><cell>30</cell><cell>10</cell></row><row><cell>5</cell><cell>134</cell><cell>36</cell><cell>32</cell><cell>15</cell><cell>59</cell><cell>24</cell></row><row><cell>6</cell><cell>2 7</cell><cell>1 1</cell><cell>5</cell><cell>4</cell><cell>4</cell><cell>2</cell></row><row><cell>7</cell><cell>167</cell><cell>33</cell><cell>4</cell><cell>BDL</cell><cell>BDL</cell><cell>BDL</cell></row><row><cell>8</cell><cell>194</cell><cell>20</cell><cell>8</cell><cell>4</cell><cell>14</cell><cell>5</cell></row><row><cell>9</cell><cell>62</cell><cell>8</cell><cell>8</cell><cell>BDL</cell><cell>73</cell><cell>14</cell></row><row><cell>10</cell><cell>56</cell><cell>3</cell><cell>5</cell><cell>BDL</cell><cell>BDL</cell><cell>BDL</cell></row><row><cell>11</cell><cell>164</cell><cell>29</cell><cell>21</cell><cell>8</cell><cell>5</cell><cell>2</cell></row><row><cell>12</cell><cell>197</cell><cell>36</cell><cell>23</cell><cell>9</cell><cell>11</cell><cell>5</cell></row><row><cell>13</cell><cell>28</cell><cell>3</cell><cell>BDL</cell><cell>BDL</cell><cell>2</cell><cell>BDL</cell></row><row><cell>14</cell><cell>28</cell><cell>10</cell><cell>BDL</cell><cell>BDL</cell><cell>3</cell><cell>2</cell></row><row><cell>15</cell><cell>246</cell><cell>27</cell><cell>90</cell><cell>27</cell><cell>64</cell><cell>18</cell></row><row><cell>16</cell><cell>49</cell><cell>17</cell><cell>5</cell><cell>4</cell><cell>3</cell><cell>2</cell></row><row><cell>17</cell><cell>402</cell><cell>78</cell><cell>8</cell><cell>4</cell><cell>35</cell><cell>12</cell></row><row><cell>18</cell><cell>362</cell><cell>26</cell><cell>39</cell><cell>7</cell><cell>123</cell><cell>14</cell></row><row><cell>19</cell><cell>87</cell><cell>2</cell><cell>59</cell><cell>4</cell><cell>10</cell><cell>BDL</cell></row><row><cell>20</cell><cell>208</cell><cell>20</cell><cell></cell><cell>13</cell><cell>4</cell><cell>2</cell></row><row><cell>21</cell><cell>61</cell><cell>6</cell><cell>BDL</cell><cell>BDL</cell><cell>5</cell><cell>2</cell></row><row><cell>22</cell><cell>52</cell><cell>4</cell><cell>25</cell><cell>8</cell><cell>3</cell><cell>BDL</cell></row><row><cell>23</cell><cell>273</cell><cell>43</cell><cell></cell><cell>63</cell><cell>19</cell><cell>6</cell></row><row><cell>24</cell><cell>473</cell><cell>20</cell><cell>BDL</cell><cell>BDL</cell><cell>4</cell><cell>BDL</cell></row><row><cell>25</cell><cell>112</cell><cell>10</cell><cell>26</cell><cell>6</cell><cell>26</cell><cell>9</cell></row><row><cell>26</cell><cell>55</cell><cell>8</cell><cell>BDL</cell><cell>BDL</cell><cell>BDL</cell><cell>BDL</cell></row><row><cell>27</cell><cell>56</cell><cell>2</cell><cell>118</cell><cell>10</cell><cell>30</cell><cell>3</cell></row><row><cell>28</cell><cell>72</cell><cell>17</cell><cell>11</cell><cell>6</cell><cell>5</cell><cell>3</cell></row><row><cell>29</cell><cell>82</cell><cell>7</cell><cell>43</cell><cell>9</cell><cell>12</cell><cell>4</cell></row><row><cell>30</cell><cell>143</cell><cell>6</cell><cell>79</cell><cell>6</cell><cell>20</cell><cell>2</cell></row><row><cell>Median (IQR)</cell><cell>123 (56-253)</cell><cell>17 (7-33)</cell><cell>16 (4-42)</cell><cell>6 (BDL-10)</cell><cell>10 (3-30)</cell><cell>3 (BDL-9)</cell></row><row><cell></cell><cell>0 BDL</cell><cell>0 BDL</cell><cell>5 BDL</cell><cell>9 BDL</cell><cell>4 BDL</cell><cell>8 BDL</cell></row><row><cell cols="7">Detection limit of 0.2 kU/L in diluted NasSec reflecting a detection limit of 4 kU/L for FDs (1:20 dilution) and 2 kU/L for SPs (1:10 dilution) in the undiluted NasSec. For patient</cell></row><row><cell cols="5">20 and patient 23, total IgE was not measured in NasSec collected with FDs because not enough volume was available.</cell><cell></cell><cell></cell></row><row><cell cols="3">BDL, Below detection limit; IQR, interquartile range.</cell><cell></cell><cell></cell><cell></cell><cell></cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_5"><head>TABLE E3 .</head><label>E3</label><figDesc><div><p><s>Sensitivity and specificity of the microarray for different cutoffs of sIgE positivity in NasSec, with the results in serumz as reference, considering all the 15 and at least 1 of the major allergen molecules (nDer p 1, rDer p 2, rDer p 23, nDer f 1, rDer f 2)</s></p></div></figDesc><table><row><cell></cell><cell></cell><cell>sIgE CO</cell><cell>sIgE CO</cell><cell>sIgE CO</cell><cell>sIgE CO</cell><cell>sIgE CO</cell></row><row><cell>Collection method</cell><cell>Allergen molecules</cell><cell>0.01 ISU</cell><cell>0.02 ISU</cell><cell>0.03 ISU</cell><cell>0.1 ISU</cell><cell>0.3 ISU</cell></row><row><cell>Filter disk</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell>Any*</cell><cell>90/83</cell><cell>90/100</cell><cell>90/100</cell><cell>87/100</cell><cell>73/100</cell></row><row><cell></cell><cell>All</cell><cell>77/91</cell><cell>72/98</cell><cell>71/100</cell><cell>59/100</cell><cell>44/100</cell></row><row><cell>Sinus pack</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell>Any*</cell><cell>90/66</cell><cell>90/100</cell><cell>87/100</cell><cell>83/100</cell><cell>73/100</cell></row><row><cell></cell><cell>All</cell><cell>75/89</cell><cell>69/97</cell><cell>68/99</cell><cell>62/100</cell><cell>49/100</cell></row><row><cell cols="6">Sensitivity/specificity shown for the respective cutoff levels in NasSec. Sensitivity/specifivity in boldface for the selected cutoff level of 0.03 ISU in NasSec.</cell><cell></cell></row><row><cell>CO, Cutoff.</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell cols="4">*Outcomes referred to at least 1 of the major allergenic molecules (nDer p 1, rDer p 2, rDer p 23, nDer f 1, rDer f 2).</cell><cell></cell><cell></cell><cell></cell></row><row><cell cols="7">Outcomes referred to all 15 molecules, including rDer p 4, rDer p 21, rDer p 11, rDer p 18, Clone 16, rDer p 10, rDer p 15, and rDer p 14, all characterized by a low positive</cell></row><row><cell>sample size (n &lt; 5).</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell cols="2">àCuttoff of sIgE positivity in serum: 0.1 ISU.</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_6"><head>TABLE E4 .</head><label>E4</label><figDesc><div><p><s>Prevalence of detectable IgE antibodies to each of the 15 HDM allergen molecules among the different samples (serum and NasSec) collected from 29 nonallergic controls and 30 HDM-allergic patients with AR at the first test 31%) microarray tests performed were positive among the 29 controls, whereas 423 of 1350 (31.33%) microarray tests performed were positive among the 30 patients with AR.</s><s>Cutoff in diluted NasSec of 0.03 ISU reflecting a cutoff in the undiluted NasSec of 0.6 ISU for FDs (1:20 dilution) and 0.3 ISU for SPs (1:10 dilution).</s></p></div></figDesc><table><row><cell></cell><cell></cell><cell cols="2">Nonallergic subjects (n 5 29)</cell><cell></cell><cell></cell><cell></cell><cell cols="4">HDM-allergic patients with AR (n 5 30)</cell><cell></cell></row><row><cell>Serum</cell><cell></cell><cell>FD</cell><cell></cell><cell>SP</cell><cell></cell><cell>Serum</cell><cell></cell><cell>FD</cell><cell></cell><cell>SP</cell><cell></cell></row><row><cell cols="2">IgE &gt; _ 0.1 ISU</cell><cell cols="2">IgE &gt; _ 0.6 ISU</cell><cell cols="2">IgE &gt; _ 0.3 ISU</cell><cell cols="2">IgE &gt; _ 0.1 ISU</cell><cell cols="2">IgE &gt; _ 0.6 ISU</cell><cell cols="2">IgE &gt; _ 0.3 ISU</cell></row><row><cell>n</cell><cell>%</cell><cell>n</cell><cell>%</cell><cell>n</cell><cell>%</cell><cell>n</cell><cell>%</cell><cell>n</cell><cell>%</cell><cell>n</cell><cell>%</cell></row><row><cell>D pteronyssinus</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>nDer p 1</cell><cell>0</cell><cell>0</cell><cell>0</cell><cell>0</cell><cell>0</cell><cell>24</cell><cell>80</cell><cell>11</cell><cell>37</cell><cell>14</cell><cell>47</cell></row><row><cell>rDer p 2</cell><cell>0</cell><cell>0</cell><cell>0</cell><cell>0</cell><cell>0</cell><cell>29</cell><cell>97</cell><cell>26</cell><cell>87</cell><cell>25</cell><cell>83</cell></row><row><cell>rDer p 4</cell><cell>0</cell><cell>0</cell><cell>0</cell><cell>0</cell><cell>0</cell><cell>7</cell><cell>23</cell><cell>1</cell><cell>3</cell><cell>2</cell><cell>7</cell></row><row><cell>rDer p 5</cell><cell>0</cell><cell>0</cell><cell>0</cell><cell>4</cell><cell>14</cell><cell>10</cell><cell>33</cell><cell>8</cell><cell>27</cell><cell>8</cell><cell>27</cell></row><row><cell>rDer p 7</cell><cell>0</cell><cell>0</cell><cell>0</cell><cell>0</cell><cell>0</cell><cell>9</cell><cell>30</cell><cell>7</cell><cell>23</cell><cell>6</cell><cell>20</cell></row><row><cell>rDer p 10</cell><cell>0</cell><cell>0</cell><cell>0</cell><cell>0</cell><cell>0</cell><cell>1</cell><cell>3</cell><cell>0</cell><cell>0</cell><cell>1</cell><cell>3</cell></row><row><cell>rDer p 11</cell><cell>0</cell><cell>0</cell><cell>0</cell><cell>0</cell><cell>0</cell><cell>1</cell><cell>3</cell><cell>0</cell><cell>0</cell><cell>0</cell><cell>0</cell></row><row><cell>rDer p 14</cell><cell>0</cell><cell>0</cell><cell>0</cell><cell>0</cell><cell>0</cell><cell>0</cell><cell>0</cell><cell>0</cell><cell>0</cell><cell>0</cell><cell>0</cell></row><row><cell>rDer p 15</cell><cell>0</cell><cell>0</cell><cell>0</cell><cell>0</cell><cell>0</cell><cell>1</cell><cell>3</cell><cell>1</cell><cell>3</cell><cell>0</cell><cell>0</cell></row><row><cell>Clone 16</cell><cell>0</cell><cell>0</cell><cell>0</cell><cell>0</cell><cell>0</cell><cell>3</cell><cell>10</cell><cell>1</cell><cell>3</cell><cell>1</cell><cell>3</cell></row><row><cell>rDer p 18</cell><cell>0</cell><cell>0</cell><cell>0</cell><cell>0</cell><cell>0</cell><cell>1</cell><cell>3</cell><cell>2</cell><cell>7</cell><cell>0</cell><cell>0</cell></row><row><cell>rDer p 21</cell><cell>0</cell><cell>0</cell><cell>0</cell><cell>0</cell><cell>0</cell><cell>7</cell><cell>23</cell><cell>4</cell><cell>13</cell><cell>4</cell><cell>13</cell></row><row><cell>rDer p 23</cell><cell>0</cell><cell>0</cell><cell>0</cell><cell>0</cell><cell>0</cell><cell>26</cell><cell>87</cell><cell>21</cell><cell>70</cell><cell>21</cell><cell>70</cell></row><row><cell>D farinae</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>nDer f 1</cell><cell>0</cell><cell>0</cell><cell>0</cell><cell>0</cell><cell>0</cell><cell>25</cell><cell>83</cell><cell>17</cell><cell>57</cell><cell>18</cell><cell>60</cell></row><row><cell>rDer f 2</cell><cell>0</cell><cell>0</cell><cell>0</cell><cell>0</cell><cell>0</cell><cell>29</cell><cell>97</cell><cell>26</cell><cell>87</cell><cell>25</cell><cell>83</cell></row><row><cell>Overall, 4 of 1305 (0.</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_7"><head>TABLE E5 .</head><label>E5</label><figDesc><div><p><s>Prevalence of detectable IgE antibodies to each of the 15 HDM allergen molecules among the different samples (serum and NasSec) collected from 13 patients with AR at the second test</s></p></div></figDesc><table><row><cell></cell><cell cols="2">Serum</cell><cell>FD</cell><cell></cell><cell>SP</cell><cell></cell><cell>EP</cell><cell></cell></row><row><cell></cell><cell>n</cell><cell>%</cell><cell>n</cell><cell>%</cell><cell>n</cell><cell>%</cell><cell>n</cell><cell>%</cell></row><row><cell>D pteronyssinus</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>nDer p 1</cell><cell>10</cell><cell>77</cell><cell>9</cell><cell>69</cell><cell>10</cell><cell>77</cell><cell>10</cell><cell>77</cell></row><row><cell>rDer p 2</cell><cell>13</cell><cell>100</cell><cell>11</cell><cell>85</cell><cell>12</cell><cell>92</cell><cell>12</cell><cell>92</cell></row><row><cell>rDer p 4</cell><cell>1</cell><cell>8</cell><cell>4</cell><cell>31</cell><cell>3</cell><cell>23</cell><cell>4</cell><cell>31</cell></row><row><cell>rDer p 5</cell><cell>4</cell><cell>31</cell><cell>4</cell><cell>31</cell><cell>3</cell><cell>23</cell><cell>5</cell><cell>38</cell></row><row><cell>rDer p 7</cell><cell>5</cell><cell>38</cell><cell>3</cell><cell>23</cell><cell>3</cell><cell>23</cell><cell>3</cell><cell>23</cell></row><row><cell>rDer p 10</cell><cell>1</cell><cell>8</cell><cell>0</cell><cell>0</cell><cell>0</cell><cell>0</cell><cell>0</cell><cell>0</cell></row><row><cell>rDer p 11</cell><cell>0</cell><cell>0</cell><cell>0</cell><cell>0</cell><cell>0</cell><cell>0</cell><cell>4</cell><cell>3 1</cell></row><row><cell>rDer p 14</cell><cell>0</cell><cell>0</cell><cell>0</cell><cell>0</cell><cell>0</cell><cell>0</cell><cell>0</cell><cell>0</cell></row><row><cell>rDer p 15</cell><cell>1</cell><cell>8</cell><cell>0</cell><cell>0</cell><cell>0</cell><cell>0</cell><cell>0</cell><cell>0</cell></row><row><cell>Clone 16</cell><cell>1</cell><cell>8</cell><cell>1</cell><cell>8</cell><cell>1</cell><cell>8</cell><cell>0</cell><cell>0</cell></row><row><cell>rDer p 18</cell><cell>4</cell><cell>31</cell><cell>3</cell><cell>23</cell><cell>2</cell><cell>15</cell><cell>3</cell><cell>23</cell></row><row><cell>rDer p 21</cell><cell>2</cell><cell>15</cell><cell>0</cell><cell>0</cell><cell>0</cell><cell>0</cell><cell>0</cell><cell>0</cell></row><row><cell>rDer p 23</cell><cell>10</cell><cell>77</cell><cell>8</cell><cell>62</cell><cell>9</cell><cell>69</cell><cell>8</cell><cell>62</cell></row><row><cell>D farinae</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>nDer f 1</cell><cell>10</cell><cell>77</cell><cell>8</cell><cell>62</cell><cell>9</cell><cell>69</cell><cell>8</cell><cell>62</cell></row><row><cell>rDer f 2</cell><cell>13</cell><cell>100</cell><cell>11</cell><cell>85</cell><cell>12</cell><cell>92</cell><cell>12</cell><cell>92</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_8"><head>TABLE E6 .</head><label>E6</label><figDesc><div><p><s>Prediction of IgE responses in serum by testing IgE responses in NasSec collected with FDs, SPs, and EPs in 13 patients with AR at the second test Positive likelihood ratio; LR2, negative likelihood ratio; NA, not applicable/available; NPV, negative predictive value; PPV, positive predictive value; r s , Spearman rank correlation coefficient.</s><s>*Exact binomial confidence limits (95% CI) for test sensitivity, specificity, PPV, and NPV.</s><s>r s (P &lt; .05).</s><s>àIncluding outcomes of rDer p 4, rDer p 21, rDer p 11, rDer p 18, Clone 16, rDer p 10, rDer p 15, and rDer p 14, all characterized by a low positive sample size (n &lt; 5).</s><s>§r s (P &lt; .001).</s></p></div></figDesc><table><row><cell></cell><cell>Sensitivity</cell><cell cols="2">Specificity</cell><cell></cell><cell>PPV</cell><cell></cell><cell>NPV</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>%</cell><cell>95% CI*</cell><cell>%</cell><cell>95% CI*</cell><cell>%</cell><cell>95% CI*</cell><cell>%</cell><cell>95% CI*</cell><cell>Accuracy, %</cell><cell>LR+</cell><cell>LR2</cell><cell>r s</cell></row><row><cell>FD vs serum</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>nDer p 1</cell><cell>23-83</cell><cell>100</cell><cell>19-100</cell><cell>100</cell><cell>55-100</cell><cell>75</cell><cell>19-99</cell><cell>92</cell><cell>NA</cell><cell>0.1</cell><cell>0.57</cell></row><row><cell>rDer p 2</cell><cell>53-97</cell><cell>NA</cell><cell>NA</cell><cell>100</cell><cell>67-100</cell><cell>0</cell><cell>0-80</cell><cell>85</cell><cell>NA</cell><cell>NA</cell><cell>0.28</cell></row><row><cell>rDer p 5</cell><cell>28-100</cell><cell>100</cell><cell>55-100</cell><cell>100</cell><cell>28-100</cell><cell>100</cell><cell>55-100</cell><cell>100</cell><cell>NA</cell><cell>0.0</cell><cell>0.2</cell></row><row><cell>rDer p 7</cell><cell>14-94</cell><cell>100</cell><cell>51-100</cell><cell>100</cell><cell>19-100</cell><cell>80</cell><cell>44-97</cell><cell>85</cell><cell>NA</cell><cell>0.4</cell><cell>0.5</cell></row><row><cell>rDer p 23</cell><cell>48-97</cell><cell>100</cell><cell>9-100</cell><cell>100</cell><cell>55-100</cell><cell>50</cell><cell>6-93</cell><cell>85</cell><cell>NA</cell><cell>0.2</cell><cell>0.72</cell></row><row><cell>nDer f 1</cell><cell>44-97</cell><cell>100</cell><cell>19-100</cell><cell>100</cell><cell>51-100</cell><cell>60</cell><cell>14-94</cell><cell>85</cell><cell>NA</cell><cell>0.2</cell><cell>0.48</cell></row><row><cell>rDer f 2</cell><cell>53-97</cell><cell>NA</cell><cell>NA</cell><cell>100</cell><cell>67-100</cell><cell>0</cell><cell>0-80</cell><cell>85</cell><cell>NA</cell><cell>NA</cell><cell>0.27</cell></row><row><cell>Allà</cell><cell>72-89</cell><cell>99</cell><cell>97-99</cell><cell>96</cell><cell>88-99</cell><cell>95</cell><cell>92-97</cell><cell>95</cell><cell>86.5</cell><cell>0.2</cell><cell>0.60 §</cell></row><row><cell>SP vs serum</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>nDer p 1</cell><cell>55-100</cell><cell>67</cell><cell>9-99</cell><cell>90</cell><cell>55-99</cell><cell>67</cell><cell>9-99</cell><cell>85</cell><cell>2.7</cell><cell>0.2</cell><cell>0.50</cell></row><row><cell>rDer p 2</cell><cell>62-99</cell><cell>NA</cell><cell>NA</cell><cell>100</cell><cell>69-100</cell><cell>0</cell><cell>0-30</cell><cell>92</cell><cell>NA</cell><cell>NA</cell><cell>0.29</cell></row><row><cell>rDer p 5</cell><cell>19-99</cell><cell>100</cell><cell>55-100</cell><cell>100</cell><cell>19-100</cell><cell>90</cell><cell>55-99</cell><cell>92</cell><cell>NA</cell><cell>0.3</cell><cell>0.50</cell></row><row><cell>rDer p 7</cell><cell>14-94</cell><cell>100</cell><cell>51-100</cell><cell>100</cell><cell>19-100</cell><cell>80</cell><cell>44-97</cell><cell>85</cell><cell>NA</cell><cell>0.4</cell><cell>0.50</cell></row><row><cell>rDer p 23</cell><cell>39-94</cell><cell>100</cell><cell>9-100</cell><cell>100</cell><cell>51-100</cell><cell>40</cell><cell>5-85</cell><cell>77</cell><cell>NA</cell><cell>0.3</cell><cell>0.50</cell></row><row><cell>nDer f 1</cell><cell>44-97</cell><cell>67</cell><cell>9-99</cell><cell>89</cell><cell>51-99</cell><cell>50</cell><cell>6-93</cell><cell>77</cell><cell>2.4</cell><cell>0.3</cell><cell>0.40</cell></row><row><cell>rDer f 2</cell><cell>62-99</cell><cell>NA</cell><cell>NA</cell><cell>100</cell><cell>69-100</cell><cell>0</cell><cell>0-30</cell><cell>92</cell><cell>NA</cell><cell>NA</cell><cell>0.17</cell></row><row><cell>Allà</cell><cell>65-84</cell><cell>98</cell><cell>95-99</cell><cell>92</cell><cell>83-96</cell><cell>94</cell><cell>90-96</cell><cell>93</cell><cell>40.2</cell><cell>0.2</cell><cell>0.46 §</cell></row><row><cell>EP vs serum</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>nDer p 1</cell><cell>58-100</cell><cell>100</cell><cell>19-100</cell><cell>100</cell><cell>58-100</cell><cell>100</cell><cell>19-100</cell><cell>100</cell><cell>NA</cell><cell>0.0</cell><cell>0.55</cell></row><row><cell>rDer p 2</cell><cell>62-99</cell><cell>NA</cell><cell>NA</cell><cell>100</cell><cell>69-100</cell><cell>0</cell><cell>0-30</cell><cell>92</cell><cell>NA</cell><cell>NA</cell><cell>0.30</cell></row><row><cell>rDer p 5</cell><cell>28-100</cell><cell>89</cell><cell>51-99</cell><cell>80</cell><cell>28-99</cell><cell>100</cell><cell>51-100</cell><cell>92</cell><cell>9.0</cell><cell>0.0</cell><cell>0.40</cell></row><row><cell>rDer p 7</cell><cell>14-94</cell><cell>100</cell><cell>51-100</cell><cell>100</cell><cell>19-100</cell><cell>80</cell><cell>44-97</cell><cell>85</cell><cell>NA</cell><cell>0.4</cell><cell>0.50</cell></row><row><cell>rDer p 23</cell><cell>58-99</cell><cell>100</cell><cell>9-100</cell><cell>100</cell><cell>58-100</cell><cell>67</cell><cell>9-99</cell><cell>92</cell><cell>NA</cell><cell>0.1</cell><cell>0.56</cell></row><row><cell>nDer f 1</cell><cell>44-97</cell><cell>100</cell><cell>19-100</cell><cell>100</cell><cell>51-100</cell><cell>60</cell><cell>14-94</cell><cell>85</cell><cell>NA</cell><cell>0.2</cell><cell>0.40</cell></row><row><cell>rDer f 2</cell><cell>62-99</cell><cell>NA</cell><cell>NA</cell><cell>100</cell><cell>69-100</cell><cell>0</cell><cell>0-30</cell><cell>92</cell><cell>NA</cell><cell>NA</cell><cell>0.22</cell></row><row><cell>Allà</cell><cell>71-89</cell><cell>92</cell><cell>86-96</cell><cell>87</cell><cell>77-94</cell><cell>89</cell><cell>81-93</cell><cell>88</cell><cell>10.8</cell><cell>0.2</cell><cell>0.52 §</cell></row><row><cell>LR2,</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row></table></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">J ALLERGY CLIN IMMUNOL VOLUME 140, NUMBER 1 LETTERS TO THE EDITOR 301</note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">J ALLERGY CLIN IMMUNOLJULY 2017</note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">J ALLERGY CLIN IMMUNOL VOLUME 140, NUMBER 1 LETTERS TO THE EDITOR 303</note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">J ALLERGY CLIN IMMUNOL VOLUME 140, NUMBER 1</note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">J ALLERGY CLIN IMMUNOL VOLUME 140, NUMBER</note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">J ALLERGY CLIN IMMUNOL VOLUME 140, NUMBER LETTERS TO THE EDITOR 303.e8</note>
		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>We thank Gabriele Holtappels (Upper Airway Research Laboratory, Ghent) for her advise on how to process NasSec and how to perform measurements in NasSec.</s><s>We thank Alexander Rohrbach for his laboratory support (Charit e-Universit€ atsmedizin, Berlin).</s><s>We thank Sander De Bruyne and Eveline van Mulders (2 medical students of Ghent University) for their help with patient recruitment and sample collection.</s><s>Finally, we thank all patients for their participation in this study.</s></p><p><s>Margot Berings, MD</s></p></div>
			</div>

			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Local production of specific IgE antibodies in allergicrhinitis patients with negative skin tests</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">G</forename><surname>Huggins</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Brostoff</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Lancet</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="page" from="148" to="150" />
			<date type="published" when="1975">1975</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Local production of IgG, IgA and IgE antibodies in grass pollen hay fever</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">A</forename><surname>Platts-Mills</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Immunol</title>
		<imprint>
			<biblScope unit="volume">122</biblScope>
			<biblScope unit="page" from="2218" to="2225" />
			<date type="published" when="1979">1979</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">The who, where, and when of IgE in allergic airway disease</title>
		<author>
			<persName><forename type="first">M</forename><surname>Dullaers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>De Bruyne</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Ramadani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">J</forename><surname>Gould</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Gevaert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">N</forename><surname>Lambrecht</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Allergy Clin Immunol</title>
		<imprint>
			<biblScope unit="volume">129</biblScope>
			<biblScope unit="page" from="635" to="645" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Objective monitoring of nasal airway inflammation in rhinitis</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">H</forename><surname>Howarth</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">G</forename><surname>Persson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">O</forename><surname>Meltzer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">R</forename><surname>Jacobson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">R</forename><surname>Durham</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">E</forename><surname>Silkoff</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Allergy Clin Immunol</title>
		<imprint>
			<biblScope unit="volume">115</biblScope>
			<biblScope unit="page" from="S414" to="441" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Local allergic rhinitis: concept, pathophysiology, and management</title>
		<author>
			<persName><forename type="first">C</forename><surname>Rond On</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Campo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Togias</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">J</forename><surname>Fokkens</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">R</forename><surname>Durham</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">G</forename><surname>Powe</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Allergy Clin Immunol</title>
		<imprint>
			<biblScope unit="volume">129</biblScope>
			<biblScope unit="page" from="1460" to="1467" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Diagnostic tools in Rhinology EAACI position paper</title>
		<author>
			<persName><forename type="first">G</forename><surname>Scadding</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Hellings</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Alobid</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Bachert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Fokkens</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">G</forename><surname>Van Wijk</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Transl Allergy</title>
		<imprint>
			<biblScope unit="volume">1</biblScope>
			<biblScope unit="issue">2</biblScope>
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Measurement of Japanese cedar pollen-specific IgE in nasal secretions</title>
		<author>
			<persName><forename type="first">H</forename><surname>Sakaida</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Masuda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Takeuchi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Allergol Int</title>
		<imprint>
			<biblScope unit="volume">63</biblScope>
			<biblScope unit="page" from="467" to="473" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Detecting local immunoglobulin E from mucosal brush biopsy of the inferior turbinates using microarray analysis</title>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">R</forename><surname>Reisacher</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Int Forum Allergy Rhinol</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="page" from="399" to="403" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Advances in allergen-microarray technology for diagnosis and monitoring of allergy: the MeDALL allergen-chip</title>
		<author>
			<persName><forename type="first">C</forename><surname>Lupinek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Wollmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Baar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Banerjee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Breiteneder</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">M</forename><surname>Broecker</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Methods</title>
		<imprint>
			<biblScope unit="volume">66</biblScope>
			<biblScope unit="page" from="106" to="119" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<monogr>
		<title level="m" type="main">Available online</title>
		<idno type="DOI">10.1016/j.jaci.2016.11.047</idno>
		<ptr target="http://dx.doi.org/10.1016/j.jaci.2016.11.047" />
		<imprint>
			<date type="published" when="2017-02-21">February 21. 2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">The response to nasal allergen provocation with grass pollen is reduced in patients with chronic rhinosinusitis with nasal polyposis and grass sensitization</title>
		<author>
			<persName><surname>References E1</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Calus</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Devuyst</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Van Zele</surname></persName>
		</author>
		<author>
			<persName><forename type="first">De</forename><surname>Ruyck</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Derycke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Bachert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Exp Allergy</title>
		<imprint>
			<biblScope unit="volume">46</biblScope>
			<biblScope unit="page" from="555" to="563" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Collection of nasal secretions for immunological analysis</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">B</forename><surname>Watelet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Gevaert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Holtappels</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Van Cauwenberge</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Bachert</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur Arch Otorhinolaryngol</title>
		<imprint>
			<biblScope unit="volume">261</biblScope>
			<biblScope unit="page" from="242" to="246" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
